Bogemann M, Shore ND, Smith MR, Tammela TLJ, et al. Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial. Eur Urol 2022 Sep 8. pii: S0302-2838(22)02532.
PMID: 36089529